-
Mashup Score: 0
Asthma and allergic disease impact millions of patients and are associated with high costs. Up to 30% of all medical care involves wasted spending. Across the spectrum of care provided by the allergist-immunologist, there are opportunities to improve value and reduce medical waste. Several examples highlight this reality. Evidence suggests that most patients may receive cost-effective care in the…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Despite the growing attention to evaluating care from the patient perspective, the most common definitions and measurements of quality are currently defined by physicians and health systems. Studies have demonstrated how a lack of patient input can lead to discrepancies between patients’ and physicians’ assessments of quality and, subsequently, worse patient outcomes. Although quality measures…
Source: Journal of Hand SurgeryCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis - 2 year(s) ago
Drug repurposing is a major field of value-added medicine. It involves investigating and evaluating existing drugs for new therapeutic purposes that address unmet healthcare needs. Several unmet needs in allergic rhinitis could be improved by drug repurposing. This could be game-changing for disease management. Current medications for allergic rhinitis are centered on continuous long-term…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 3Registration - 2 year(s) ago
Thu, Dec 8, 2022 3:00 PM – 4:00 PM UTC At this virtual briefing, executives from leading hospitals, health systems and insurers will convene with policy leaders to discuss strategies for working together effectively to achieve business goals, lower costs, streamline patient experiences and improve patient outcomes. …
Source: register.gotowebinar.comCategories: General Medicine News, Latest HeadlinesTweet-
As policy continues to prioritize interoperability and #value-based care, providers and payers must collaborate. Join executives from leading hospitals, systems and insurers to discuss strategies: https://t.co/mfhkVrLFZl @TMobile, @medallion and @StansonHealth #MHPayerProvider https://t.co/dKxUMYivd4
-
-
Mashup Score: 3Registration - 2 year(s) ago
Tue, Nov 15, 2022 7:00 PM – 8:00 PM UTC Value-based care is rapidly evolving and changing the way health systems of all sizes and backgrounds approach healthcare delivery. As CMS continues to emphasize its goal of having every Medicare beneficiary in an accountable care plan by 2030, health systems should engage in…
Source: register.gotowebinar.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Registration - 2 year(s) ago
Tue, Nov 15, 2022 7:00 PM – 8:00 PM UTC Value-based care is rapidly evolving and changing the way health systems of all sizes and backgrounds approach healthcare delivery. As CMS continues to emphasize its goal of having every Medicare beneficiary in an accountable care plan by 2030, health systems should engage in…
Source: register.gotowebinar.comCategories: General Medicine News, Latest HeadlinesTweet-
Interested in learning how leading health systems leverage an integrated #value-based care system? November 15, discover benefits of the Medicare Shared Savings Program and how to scale infrastructure to support initiatives: https://t.co/D2aJZWX5Kp #Sponsored by @signifyhealth. https://t.co/uZWaoCuotH
-
-
Mashup Score: 0Randomized controlled trials in de-implementation research: a systematic scoping review - Implementation Science - 2 year(s) ago
Background Healthcare costs are rising, and a substantial proportion of medical care is of little value. De-implementation of low-value practices is important for improving overall health outcomes and reducing costs. We aimed to identify and synthesize randomized controlled trials (RCTs) on de-implementation interventions and to provide guidance to improve future research. Methods MEDLINE and…
Source: BioMed CentralCategories: Hem/Oncs, Latest HeadlinesTweet-
.@ImplementSci: #Implementation science: "Healthcare #costs are rising, and a substantial proportion of medical care is of little #value". De-implementation of low-value practices is important for improving overall health outcomes and reducing costs. Read: https://t.co/Jpllw83qf1 https://t.co/cAtHQMtDrF
-
-
Mashup Score: 17
Artificial intelligence and machine learning have reached enterprise maturity – they are essential components in information architecture.
Source: Tech MonitorCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
On Aug 25, 2022, in reply to the final ruling on an alternative payment model for radiation oncology by the Centers for Medicare and Medicaid Services (CMS), Laura Dawson, Chair of the Board of Directors of the American Society for Radiation Oncology (ASTRO), expressed support for a value-based radiotherapy payment framework in place in the USA.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Today’s health system CFOs are navigating value-based agreements and balance sheets for new care models.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet
In Current Issue (FREE)! #Value-Based, #CostEffective #Care: The Role of the #Allergist- #Immunologist https://t.co/Qd5sUOb1yK https://t.co/QgFLN8dE78